The Food and Drug Administration (FDA) inspected Harmar Mobility, LLC. in Raymore on Feb. 6, as indicated by data posted on the FDA’s website.
The inspection addressed the following areas:
- Compliance: Devices
- Postmarket Assurance: Devices
The final report concluded that Harmar Mobility, LLC. was not required to implement any changes to its management or operations.
The FDA regularly inspects facilities nationwide to determine whether workplaces and products comply with FDA laws and regulations established to protect public health. The agency later makes inspection findings public.
According to its website, the FDA is a federal agency tasked with overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
